Once a leading player in the global chip market, Intel is heavily investing in new facilities and advanced packaging technologies as it strives to compete with industry giants like TSMC in contract chip manufacturing.
In early trading, its shares dipped by over 4%. However, as of the last closing, the stock has surged nearly threefold this year, outperforming rivals AMD and Nvidia, and exceeding the Philadelphia Semiconductor Index’s almost 75% rise.
Multiple analysts have noted that the rising share price increases the likelihood of an equity raise to support Intel’s growth initiatives.
“As a capital-intensive business that significantly harmed its own balance sheet and future prospects by prioritizing financial engineering over physical engineering—evident in the $82 billion in share buybacks during the 2010s—it is entirely logical for Intel to seek additional funding, particularly after a five-fold stock price increase since last August,” commented Russ Mould, investment director at AJ Bell.
The rise in demand for central processing units driven by a shift toward AI agents has exceeded Intel’s current manufacturing capacity, compelling the chipmaker to elevate its capital expenditure forecast for the year from $18 billion to $20 billion in July.
Intel has also committed to high-volume chip production utilizing its 14A manufacturing process by 2028, having previously indicated that without a significant external customer, this technology might be abandoned.
Its foundry division has secured Tesla as a 14A client, and optimism about another high-profile customer has increased following US President Donald Trump’s statement that Apple would produce processors with Intel, although neither company has confirmed this.
Last month, Intel revealed a €5 billion ($5.77 billion) investment to upgrade and expand its chip manufacturing capabilities in Ireland, a project accounting for over 25% of its planned capital expenditure for 2026.
Intel intends to provide underwriters with a 30-day option to purchase up to $2.25 billion in additional shares at the offering price, excluding discounts.
JPMorgan Securities, Goldman Sachs, Morgan Stanley, and Citigroup Global Markets are serving as joint book-running managers.
